| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6159926 | The Journal of Urology | 2009 | 6 Pages |
Abstract
MMP1 and MMP2 may protect against prostate cancer development and MMP9 may be related to higher risk. In contrast, MMP9 polymorphism was associated with a lower Gleason score and MMP2 polymorphism was associated with nonorgan confined disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Sabrina Thalita dos Reis, José Jr., Fabiola Elizabeth Villanova, Priscila Maria de Andrade Borra, Alberto Azoubel Antunes, Marcos Francisco Dall'oglio, Miguel Srougi, Katia Ramos Moreira Leite,